Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 2
2012 2
2013 8
2014 12
2015 16
2016 12
2017 7
2018 3
2019 9
2020 13
2021 14
2022 8
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
Kakogiannos N, Ferrari L, Giampietro C, Scalise AA, Maderna C, Ravà M, Taddei A, Lampugnani MG, Pisati F, Malinverno M, Martini E, Costa I, Lupia M, Cavallaro U, Beznoussenko GV, Mironov AA, Fernandes B, Rudini N, Dejana E, Giannotta M. Kakogiannos N, et al. Among authors: ferrari l. Circ Res. 2020 Sep 25;127(8):1056-1073. doi: 10.1161/CIRCRESAHA.120.316742. Epub 2020 Jul 15. Circ Res. 2020. PMID: 32673519 Free PMC article.
Arterial hypertension and cancer.
Milan A, Puglisi E, Ferrari L, Bruno G, Losano I, Veglio F. Milan A, et al. Among authors: ferrari l. Int J Cancer. 2014 May 15;134(10):2269-77. doi: 10.1002/ijc.28334. Epub 2013 Jul 31. Int J Cancer. 2014. PMID: 23784914 Free article. Review.
Moderate asthma: burden, mechanisms and therapeutic perspectives.
De Ferrari L, Riccio AM, Braido F. De Ferrari L, et al. Curr Opin Allergy Clin Immunol. 2024 Feb 1;24(1):32-36. doi: 10.1097/ACI.0000000000000953. Epub 2023 Oct 25. Curr Opin Allergy Clin Immunol. 2024. PMID: 37877372 Review.
Do the current guidelines for asthma pharmacotherapy encourage over-treatment?
Bagnasco D, Brussino L, Caruso C, Paoletti G, Heffler E, Guida G, Calzolari E, Nicola S, De Ferrari L, Passalacqua G, Canonica GW. Bagnasco D, et al. Among authors: de ferrari l. Expert Opin Pharmacother. 2020 Aug;21(11):1283-1286. doi: 10.1080/14656566.2020.1759551. Epub 2020 May 13. Expert Opin Pharmacother. 2020. PMID: 32401551 No abstract available.
Biomarkers and severe asthma: a critical appraisal.
Chiappori A, De Ferrari L, Folli C, Mauri P, Riccio AM, Canonica GW. Chiappori A, et al. Among authors: de ferrari l. Clin Mol Allergy. 2015 Oct 1;13:20. doi: 10.1186/s12948-015-0027-7. eCollection 2015. Clin Mol Allergy. 2015. PMID: 26430389 Free PMC article. Review.
Evolving phenotypes to endotypes: is precision medicine achievable in asthma?
Bagnasco D, Passalacqua G, Caminati M, Heffler E, Menzella F, De Ferrari L, Riccio AM, Folli C, Canonica GW. Bagnasco D, et al. Among authors: de ferrari l. Expert Rev Respir Med. 2020 Feb;14(2):163-172. doi: 10.1080/17476348.2020.1703675. Epub 2020 Jan 3. Expert Rev Respir Med. 2020. PMID: 31899999 Review.
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Bagnasco D, Nicola S, Testino E, Brussino L, Pini L, Caminati M, Piccardo F, Canevari RF, Melissari L, Ioppi A, Guastini L, Lombardi C, Milanese M, Losa F, Robbiano M, De Ferrari L, Riccio AM, Guida G, Bonavia M, Fini D, Balbi F, Caruso C, Paggiaro P, Blasi F, Heffler E, Paoletti G, Canonica GW, Senna G, Passalacqua G, On Behalf Of Sani. Bagnasco D, et al. Among authors: de ferrari l. Biomedicines. 2023 Aug 30;11(9):2424. doi: 10.3390/biomedicines11092424. Biomedicines. 2023. PMID: 37760865 Free PMC article.
100 results